237 related articles for article (PubMed ID: 16783411)
1. Stimulation of sensory neuropeptide release by nociceptin/orphanin FQ leads to hyperaemia in acutely inflamed rat knees.
Zhang C; McDougall JJ
Br J Pharmacol; 2006 Aug; 148(7):938-46. PubMed ID: 16783411
[TBL] [Abstract][Full Text] [Related]
2. The role of joint nerves and mast cells in the alteration of vasoactive intestinal peptide (VIP) sensitivity during inflammation progression in rats.
McDougall JJ; Barin AK
Br J Pharmacol; 2005 May; 145(1):104-13. PubMed ID: 15723091
[TBL] [Abstract][Full Text] [Related]
3. Nociceptin/orphanin FQ evokes knee joint pain in rats via a mast cell independent mechanism.
McDougall JJ; Larson SE
Neurosci Lett; 2006 May; 398(1-2):135-8. PubMed ID: 16423460
[TBL] [Abstract][Full Text] [Related]
4. Involvement of sympathetic efferents but not capsaicin-sensitive afferents in nociceptin-mediated dual control of rat synovial blood flow.
McDougall JJ
Am J Physiol Regul Integr Comp Physiol; 2003 Jun; 284(6):R1477-85. PubMed ID: 12573980
[TBL] [Abstract][Full Text] [Related]
5. The cannabinomimetic arachidonyl-2-chloroethylamide (ACEA) acts on capsaicin-sensitive TRPV1 receptors but not cannabinoid receptors in rat joints.
Baker CL; McDougall JJ
Br J Pharmacol; 2004 Aug; 142(8):1361-7. PubMed ID: 15277316
[TBL] [Abstract][Full Text] [Related]
6. Loss of vasomotor responsiveness to the mu-opioid receptor ligand endomorphin-1 in adjuvant monoarthritic rat knee joints.
McDougall JJ; Barin AK; McDougall CM
Am J Physiol Regul Integr Comp Physiol; 2004 Apr; 286(4):R634-41. PubMed ID: 14670807
[TBL] [Abstract][Full Text] [Related]
7. Orphanin FQ/nociceptin and [Phe(1)Psi(CH(2)-NH)Gly(2)] nociceptin(1-13)-NH(2) stimulate gastric motor function in anaesthetized rats.
Krowicki ZK; Kapusta DR; Hornby PJ
Br J Pharmacol; 2000 Aug; 130(7):1639-45. PubMed ID: 10928969
[TBL] [Abstract][Full Text] [Related]
8. Nociceptin/orphanin FQ inhibits capsaicin-induced guinea-pig airway contraction through an inward-rectifier potassium channel.
Jia Y; Wang X; Aponte SI; Rivelli MA; Yang R; Rizzo CA; Corboz MR; Priestley T; Hey JA
Br J Pharmacol; 2002 Feb; 135(3):764-70. PubMed ID: 11834624
[TBL] [Abstract][Full Text] [Related]
9. Tachykinin regulation of basal synovial blood flow.
Ferrell WR; Lockhart JC; Karimian SM
Br J Pharmacol; 1997 May; 121(1):29-34. PubMed ID: 9146883
[TBL] [Abstract][Full Text] [Related]
10. Proinflammatory and vasodilator effects of nociceptin/orphanin FQ in the rat mesenteric microcirculation are mediated by histamine.
Brookes ZL; Stedman EN; Guerrini R; Lawton BK; Calo G; Lambert DG
Am J Physiol Heart Circ Physiol; 2007 Nov; 293(5):H2977-85. PubMed ID: 17766480
[TBL] [Abstract][Full Text] [Related]
11. In vivo effects of CB2 receptor-selective cannabinoids on the vasculature of normal and arthritic rat knee joints.
McDougall JJ; Yu V; Thomson J
Br J Pharmacol; 2008 Jan; 153(2):358-66. PubMed ID: 17982474
[TBL] [Abstract][Full Text] [Related]
12. Nocistatin and prepro-nociceptin/orphanin FQ 160-187 cause nociception through activation of Gi/o in capsaicin-sensitive and of Gs in capsaicin-insensitive nociceptors, respectively.
Inoue M; Kawashima T; Allen RG; Ueda H
J Pharmacol Exp Ther; 2003 Jul; 306(1):141-6. PubMed ID: 12665541
[TBL] [Abstract][Full Text] [Related]
13. Modulation of synovial blood flow by the calcitonin gene-related peptide (CGRP) receptor antagonist, CGRP(8-37).
McMurdo L; Lockhart JC; Ferrell WR
Br J Pharmacol; 1997 Jul; 121(6):1075-80. PubMed ID: 9249241
[TBL] [Abstract][Full Text] [Related]
14. Role of nociceptin/orphanin FQ receptors in the decrease of mucosal mast cells caused by acute stress in the rat colon.
Grandi D; Massi M; Guerrini R; Caló G; Morini G
Life Sci; 2011 Nov; 89(19-20):735-40. PubMed ID: 21925513
[TBL] [Abstract][Full Text] [Related]
15. The ORL-1 (NOP1) receptor ligand nociceptin/orphanin FQ (N/OFQ) inhibits neurogenic dural vasodilatation in the rat.
Bartsch T; Akerman S; Goadsby PJ
Neuropharmacology; 2002 Nov; 43(6):991-8. PubMed ID: 12423668
[TBL] [Abstract][Full Text] [Related]
16. Dose-related opposite modulation by nociceptin/orphanin FQ of substance P nociception in the nociceptors and spinal cord.
Inoue M; Shimohira I; Yoshida A; Zimmer A; Takeshima H; Sakurada T; Ueda H
J Pharmacol Exp Ther; 1999 Oct; 291(1):308-13. PubMed ID: 10490918
[TBL] [Abstract][Full Text] [Related]
17. Orphanin FQ/nociceptin potentiates [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin-Induced mu-opioid receptor phosphorylation.
Ozsoy HZ; Thakker DR; Standifer KM
Mol Pharmacol; 2005 Aug; 68(2):447-56. PubMed ID: 15890842
[TBL] [Abstract][Full Text] [Related]
18. Nocistatin inhibits 5-hydroxytryptamine release in the mouse neocortex via presynaptic Gi/o protein linked pathways.
Fantin M; Fischetti C; Trapella C; Morari M
Br J Pharmacol; 2007 Oct; 152(4):549-55. PubMed ID: 17618307
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of nociceptin on somatostatin secretion of the isolated perfused rat stomach.
Lippl F; Schusdziarra V; Huepgens K; Allescher HD
Regul Pept; 2002 Jul; 107(1-3):37-42. PubMed ID: 12137964
[TBL] [Abstract][Full Text] [Related]
20. Long-term peripheral infusion of nociceptin/orphanin FQ promotes hyperplasia, activation and migration of mucosal mast cells in the rat gastric fundus.
Grandi D; Massi M; Morini G
Peptides; 2011 Apr; 32(4):729-36. PubMed ID: 21262303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]